Measles Vaccine Uptake during the 2025 Texas Measles Outbreak in a San Antonio Military Medical Center
Journal of the Pediatric Infectious Diseases Society · 08.10.2026 · 15 (11)
DOI: 10.1093/jpids/piag111 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Journal of the Pediatric Infectious Diseases Society, online erschienen am 15.10.2026. Verfasst von Adam H Boldt und 2 weiteren Autor:innen. Beteiligte Einrichtung: Dr. B Healthcare LLC, San Antonio, Texas, United States. Hauptthemen laut MEDLINE: Measles, Disease Outbreaks, Measles-Mumps-Rubella Vaccine, Vaccination. Die Arbeit nennt 31 Literaturangaben.
Abstract (Originalsprache)
Objective
To evaluate changes in measles-containing vaccine (MCV) uptake, inclusive of measles-mumps-rubella (MMR) and measles-mumps-rubella-varicella (MMRV), by age group and over time during the 2025 Texas measles outbreak.
Methods
We conducted a retrospective, single-center, observational study comparing January through August 2024 (pre-outbreak) with the same period in 2025 (outbreak) at a military medical center in San Antonio, TX. The study evaluated MCVs administered and recorded in the electronic health record (EHR) to all patients from 0-18 years enrolled during these periods. The primary outcome was the MCV administration rate (doses per 1000 child-months). Based on this, we estimated incidence rate ratios (IRRs) with 95% CIs comparing 2025 vs 2024 overall and by age groups.
Results
MCV administration increased from 10.82 per 1000 child-months in 2024 to 13.22 per 1000 child-months in 2025, across all age groups (IRR 1.22; 95% CI, 1.11-1.34; P < .001). This increase was driven by early-dose vaccination in infants aged 6-11 months (IRR 21.09; 95% CI, 9.89-44.98) and children aged 24-47 months (IRR 4.73; 95% CI, 2.84-7.87). MCV administration rates did not clearly differ among children 12-23 months (IRR 1.08; 95% CI, 0.94-1.24), 4-5 years (IRR 1.07; 95% CI, 0.93-1.23), or 6-18 years (IRR 0.54; 95% CI, 0.28-1.06). Peak vaccine uptake occurred early in the outbreak and then declined toward baseline.
Conclusions
At a military medical center in San Antonio, the 2025 Texas measles outbreak was associated with an early transient increase in MCV uptake principally driven by early infant vaccination, and by late summer, the uptake returned toward baseline.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Dr. B Healthcare LLC, San Antonio, Texas, United States.
- Present Affiliation: Division of Primary Care, Connecticut Children's Medical Center, Hartford, Connecticut, United States.
- Present Affiliation: Department of Pediatrics, University of Connecticut School of Medicine, Farmington, Connecticut, United States.
- Department of Pediatrics, Brooke Army Medical Center, Joint Base San Antonio-Fort Sam Houston, Texas, United States.
ORCID-Profile: Adam H Boldt, Sarah J Boldt, Megan L Donahue
Zitieren
APA
Boldt, A. H., Boldt, S. J., & Donahue, M. L. (2026). Measles Vaccine Uptake during the 2025 Texas Measles Outbreak in a San Antonio Military Medical Center. Journal of the Pediatric Infectious Diseases Society, 15(11). https://doi.org/10.1093/jpids/piag111
Vancouver
Boldt AH, Boldt SJ, Donahue ML. Measles Vaccine Uptake during the 2025 Texas Measles Outbreak in a San Antonio Military Medical Center. Journal of the Pediatric Infectious Diseases Society. 2026;15(11). doi:10.1093/jpids/piag111
BibTeX
@article{Boldt2026,
author = {Boldt, Adam H and Boldt, Sarah J and Donahue, Megan L},
title = {Measles Vaccine Uptake during the 2025 Texas Measles Outbreak in a San Antonio Military Medical Center},
journal = {Journal of the Pediatric Infectious Diseases Society},
year = {2026},
volume = {15},
number = {11},
doi = {10.1093/jpids/piag111}
}
EUVIMED